105 related articles for article (PubMed ID: 22144113)
41. [HIV-1 integrase inhibition by modified oligonucleotides: optimization of the inhibitor structure].
Prikazchikova TA; Volkov EM; Zubin EM; Romanova EA; Gottikh MB
Mol Biol (Mosk); 2007; 41(1):130-8. PubMed ID: 17380900
[TBL] [Abstract][Full Text] [Related]
42. Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues.
Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
Bioorg Med Chem; 2007 Jun; 15(11):3818-24. PubMed ID: 17420131
[TBL] [Abstract][Full Text] [Related]
43. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
Long YQ; Jiang XH; Dayam R; Sanchez T; Shoemaker R; Sei S; Neamati N
J Med Chem; 2004 May; 47(10):2561-73. PubMed ID: 15115398
[TBL] [Abstract][Full Text] [Related]
44. Structural dynamics of full-length retroviral integrase: a molecular dynamics analysis.
Balasubramanian S; Rajagopalan M; Ramaswamy A
J Biomol Struct Dyn; 2012; 29(6):659-70. PubMed ID: 22545997
[TBL] [Abstract][Full Text] [Related]
45. Insight into the binding mode between N-methyl pyrimidones and prototype foamy virus integrase-DNA complex by QM-polarized ligand docking and molecular dynamics simulations.
Reddy KK; Singh SK
Curr Top Med Chem; 2015; 15(1):43-9. PubMed ID: 25579571
[TBL] [Abstract][Full Text] [Related]
46. The catalytic mechanism of HIV-1 integrase for DNA 3'-end processing established by QM/MM calculations.
Ribeiro AJ; Ramos MJ; Fernandes PA
J Am Chem Soc; 2012 Aug; 134(32):13436-47. PubMed ID: 22793648
[TBL] [Abstract][Full Text] [Related]
47. Surface plasmon resonance study on HIV-1 integrase strand transfer activity.
Vaisocherová H; Snásel J; Springer T; Sípová H; Rosenberg I; Stepánek J; Homola J
Anal Bioanal Chem; 2009 Feb; 393(4):1165-72. PubMed ID: 19011840
[TBL] [Abstract][Full Text] [Related]
48. Rous sarcoma virus synaptic complex capable of concerted integration is kinetically trapped by human immunodeficiency virus integrase strand transfer inhibitors.
Pandey KK; Bera S; Korolev S; Campbell M; Yin Z; Aihara H; Grandgenett DP
J Biol Chem; 2014 Jul; 289(28):19648-58. PubMed ID: 24872410
[TBL] [Abstract][Full Text] [Related]
49. A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.
Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
Biophys J; 2008 Apr; 94(7):2443-51. PubMed ID: 17981909
[TBL] [Abstract][Full Text] [Related]
50. Molecular Insights into the Substrate-Assisted Mechanism of Viral DNA 3'-End Processing in Intasome of Prototype Foamy Virus Integrase from Molecular Dynamic and QM/MM Studies.
Krzemińska A; Świderek K
J Chem Inf Model; 2019 Jun; 59(6):2995-3005. PubMed ID: 31117511
[TBL] [Abstract][Full Text] [Related]
51. B-to-A transition in target DNA during retroviral integration.
Jóźwik IK; Li W; Zhang DW; Wong D; Grawenhoff J; Ballandras-Colas A; Aiyer S; Cherepanov P; Engelman AN; Lyumkis D
Nucleic Acids Res; 2022 Aug; 50(15):8898-8918. PubMed ID: 35947647
[TBL] [Abstract][Full Text] [Related]
52. De novo design based identification of potential HIV-1 integrase inhibitors: A pharmacoinformatics study.
Shinde PB; Bhowmick S; Alfantoukh E; Patil PC; Wabaidur SM; Chikhale RV; Islam MA
Comput Biol Chem; 2020 Oct; 88():107319. PubMed ID: 32801062
[TBL] [Abstract][Full Text] [Related]
53. A targeted DNA substrate mechanism for the inhibition of HIV-1 integrase by inhibitors with antiretroviral activity.
Ammar FF; Hobaika Z; Abdel-Azeim S; Zargarian L; Maroun RG; Fermandjian S
FEBS Open Bio; 2016 Apr; 6(4):234-50. PubMed ID: 27239438
[TBL] [Abstract][Full Text] [Related]
54. Catalytic Mechanism of Retroviral Integrase for the Strand Transfer Reaction Explored by QM/MM Calculations.
Araújo AR; Ribeiro AJ; Fernandes PA; Ramos MJ
J Chem Theory Comput; 2014 Dec; 10(12):5458-66. PubMed ID: 26583229
[TBL] [Abstract][Full Text] [Related]
55. Lead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.
Hung TC; Lee WY; Chen KB; Chan YC; Chen CY
Biomed Res Int; 2014; 2014():479367. PubMed ID: 25013783
[TBL] [Abstract][Full Text] [Related]
56. Identification and Optimization of a Novel HIV-1 Integrase Inhibitor.
Adu-Ampratwum D; Pan Y; Koneru PC; Antwi J; Hoyte AC; Kessl J; Griffin PR; Kvaratskhelia M; Fuchs JR; Larue RC
ACS Omega; 2022 Feb; 7(5):4482-4491. PubMed ID: 35155940
[TBL] [Abstract][Full Text] [Related]
57. Non-Enzymatic Functions of Retroviral Integrase: The Next Target for Novel Anti-HIV Drug Development.
Masuda T
Front Microbiol; 2011; 2():210. PubMed ID: 22016749
[TBL] [Abstract][Full Text] [Related]
58. Non-Cryogenic Structure and Dynamics of HIV-1 Integrase Catalytic Core Domain by X-ray Free-Electron Lasers.
Park JH; Yun JH; Shi Y; Han J; Li X; Jin Z; Kim T; Park J; Park S; Liu H; Lee W
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010024
[TBL] [Abstract][Full Text] [Related]
59. Molecular docking study of lamellarin analogues and identification of potential inhibitors of HIV-1 integrase strand transfer complex by virtual screening.
Eurtivong C; Choowongkomon K; Ploypradith P; Ruchirawat S
Heliyon; 2019 Nov; 5(11):e02811. PubMed ID: 31763475
[TBL] [Abstract][Full Text] [Related]
60. Molecular dynamics simulations in drug design.
Kerrigan JE
Methods Mol Biol; 2013; 993():95-113. PubMed ID: 23568466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
